Blog
About

34
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.

      Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America

      metabolism, Carbapenems, pharmacology, therapeutic use, Drug Resistance, Bacterial, Enterobacteriaceae, Enterobacteriaceae Infections, enzymology, epidemiology, microbiology, prevention & control, Humans, beta-Lactamases, Bacterial Proteins

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Over the past 10 years, dissemination of Klebsiella pneumoniae carbapenemase (KPC) has led to an increase in the prevalence of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Infections caused by CRE have limited treatment options and have been associated with high mortality rates. In the previous year, other carbapenemase subtypes, including New Delhi metallo-β-lactamase, have been identified among Enterobacteriaceae in the United States. Like KPC, these enzymes are frequently found on mobile genetic elements and have the potential to spread widely. As a result, preventing both CRE transmission and CRE infections have become important public health objectives. This review describes the current epidemiology of CRE in the United States and highlights important prevention strategies. © The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.

          Related collections

          Author and article information

          Journal
          21653305
          10.1093/cid/cir202

          Comments

          Comment on this article